Nov 27, 2024 · Gleevec is a targeted therapy cancer treatment used to treat specific types of leukemia (blood cancer), bone marrow disorders, skin cancers and certain tumors of the stomach and …

Imatinib, sold under the brand names Gleevec and Glivec (both marketed worldwide by Novartis) among others, is an oral targeted therapy medication used to treat cancer. [2]

Visit resources tailored for our patient communities and their caregivers, including information around patient assistance, disease information and related resources.

COMMON BRAND NAME (S): Gleevec What should I tell my care team before I take this medication? They need to know if you have any of these conditions: Bleeding disorder Infection, especially a viral …

Mar 24, 2022 · Imatinib (Gleevec) is an oral medication used to treat different types of cancer and blood conditions in adults. It can also be used in children with certain leukemias. This medication can …

Feb 13, 2025 · Find patient medical information for Imatinib (Gleevec, Imkeldi) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Apr 11, 2018 · NCI-supported research led to a series of discoveries that resulted in the development of imatinib (Gleevec), a landmark drug that has vastly improved the outcomes of patients with a type of …

Dec 20, 2025 · Gleevec film-coated tablets are supplied as 100 mg and 400 mg tablets for oral administration. Each 100 mg tablet contains 119.5 mg of imatinib mesylate equivalent to 100 mg of …

An open-label, multicenter, randomized trial (Gleevec versus nilotinib) was conducted to determine the efficacy of Gleevec versus nilotinib in adult patients with cytogenetically confirmed, newly diagnosed …

Consumer information about the medication imatinib (Gleevec), prescribed for the treatment of Leukemia. Information includes side effects, drug interactions, recommended dosages, and storage …